Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy

AIMS: The role of adoptive immunotherapy (AIT) for patients with hepatocellular carcinoma (HCC) who have received curative therapy is still not well illustrated. This timely meta-analysis aims to update the current evidence on efficacy and safety of AIT for patients with HCC who have received curati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Han-Yue, Liao, Ying-Yang, You, Xue-Mei, Cucchetti, Alessandro, Yuan, Bao-Hong, Li, Ru-Hong, Zhong, Jian-Hong, Li, Le-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365130/
https://www.ncbi.nlm.nih.gov/pubmed/28339493
http://dx.doi.org/10.1371/journal.pone.0174222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365130/
https://www.ncbi.nlm.nih.gov/pubmed/28339493
http://dx.doi.org/10.1371/journal.pone.0174222

Ejemplares similares